Insulin Delivery Devices Market Research Report 2022 - Global Market Demand Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 6, 2022--

The "Insulin Delivery Devices Market Research Report: By Type, Distribution Channel, End Use - Global Market Demand Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

The insulin delivery devices market 2030 revenue will likely be $39,371.8 million, compared to an estimated $16,008.0 million in 2021

Among all the devices used for administering this peptide hormone into the body, insulin pens are used the most. Pens are easier to use by individuals on themselves compared to syringes and cheaper compared to insulin pumps and other devices.

Moreover, reusable pens are cost-effective in the long run, as a single pen can be used for a long time just by simply changing the vial/refill.

Therefore, seeing the growing popularity of these devices, companies that produce them are enhancing their sales and distribution network in countries with a large diabetic population, such as China and India. Similarly, in developed countries, technologically advanced pens and ample medical reimbursements on their purchase are available.

In the years to come, market players will find numerous growth opportunities in the APAC region, which is home to the largest diabetic population in the world.

This, combined with the increasing awareness on a strict care regimen, is propelling the sale of insulin delivery devices. Among the various kinds of insulin pens, pumps, and other devices, those meant for home use continue to be the most popular.

The key insulin delivery devices market players are doing more to target the at-home consumer base. A key move in this regard is the introduction of insulin delivery devices that do not require fingersticks for calibration.

Key Findings of Insulin Delivery Devices Market Report

• The biggest reason behind the rising demand for insulin delivery devices is diabetes, which either results in insulin resistance or the stoppage in the production of this hormone.
• The IDF recorded the global prevalence of this endocrine disorder at 463 million in 2019, forecasting it to reach 578 million and 700.2 million by 2030 and 2045, respectively.
• Along with this, another key driver for the insulin delivery devices market is the growing number of obese people. Obesity, which is now considered an independent risk factor for diabetes, is a result of genetics or poor lifestyle choices.
• Another factor that ups the risk of this disease is aging, with a larger number of people aged above 45 years suffering from this disorder compared to younger people.
• Since many of the older people are not yet as comfortable with digital technologies, pharmacies continue to be the preferred place for them to buy insulin delivery devices.
• Currently, North America is the largest insulin delivery devices market because of the highly fatty diet of a large number of people, which leads to obesity and, often, diabetes. Moreover, the region has been among the first to accept technologically advanced methods of administering this hormone into the body.

Company Profiles

• Becton, Dickinson and Company
• Medtronic plc
• Tandem Diabetes Care Inc.
• Biocon Limited
• Eli Lilly and Company
• Novo Nordisk A/S
• Sanofi
• Ypsomed AG
• F. Hoffmann-La Roche Ltd.
• Insulet Corporation
• B. Braun Melsungen AG
• Wockhardt Limited

Key Topics Covered:

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Analysis Period

1.4 Market Data Reporting Unit

1.5 Market Size Breakdown by Segment

1.6 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Currency Conversion Rates

2.6 Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Definition of Market Segments

4.1 by Product

4.1.1 Insulin Pen

4.1.1.1 Reusable Pens

4.1.1.2 Disposable Pens

4.1.2 Insulin Pump

4.1.2.1 External/Tethered Pumps

4.1.2.2 Patch Pumps

4.1.3 Insulin Syringe

4.1.4 Others

4.2 by Distribution Channel

4.2.1 Pharmacies

4.2.2 E-Commerce

4.2.3 Diabetes Clinics/Centers

Chapter 5. Industry Outlook

5.1 Market Dynamics

5.1.1 Trends

5.1.1.1 Surge in the Launch of Insulin Delivery Devices

5.1.1.2 Growing Significance of Home Infusion Therapy for Diabetes Treatment

5.1.2 Drivers

5.1.2.1 Growing Diabetic Population

5.1.2.2 Technological Advancements in Insulin Delivery Devices

5.1.2.3 Surging Aging Population

5.1.3 Impact Analysis of Drivers on Market Forecast

5.1.4 Restraints

5.1.4.1 Stringent Regulatory Requirements

5.1.4.2 Complex Manufacturing of Syringes

5.1.5 Impact Analysis of Restraints on Market Forecast

5.2 Impact of Covid-19

5.3 Porter's Five Forces Analysis

Chapter 6. Global Market Size and Forecast

6.1 Overview

6.2 Market Revenue, by Type (2015-2030)

6.2.1 Insulin Pen Market Revenue, by Type (2015-2030)

6.2.2 Insulin Pump Market Revenue, by Type (2015-2030)

6.3 Market Revenue, by Distribution Channel (2015-2030)

6.4 Market Revenue, by End Use (2015-2030)

6.5 Market Revenue, by Region (2015-2030)

For more information about this report visit https://www.researchandmarkets.com/r/pyjoxg

View source version on businesswire.com:https://www.businesswire.com/news/home/20221006005815/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: DIABETES MEDICAL DEVICES OTHER HEALTH HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2022.